MT101-5

· Mthera Pharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MT101-5, covering 2024-11-25 to 2024-11-25. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Safety, Tolerability and Efficacy of MT101-5 in Subjects with Early Parkinson's Disease [Phase 2]

See pricing